Comparison of doxorubicin and cyclophosphamide (AC) versus single-agent paclitaxel (T) as adjuvant therapy for breast cancer in women with 0-3 positive axillary nodes: CALGB 40101
- Citation:
- J Clin Oncol vol 31 (15 suppl) abst 1007
- Meeting Instance:
- ASCO 2013
- Year:
- 2013
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2074
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- L. Shulman D. Berry C. Cirrincione H. Becker E. Perez R. O'Regan S. Martino C. L. Shapiro S. J. Atkin C. Schneider G. Kimmick H. Burstein L. Norton H. Muss C. Hudis E. Winer
- Networks:
- Study
- Alliance-40101
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- Keywords: